SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts.

The generation of pluripotent stem cells by somatic cell nuclear transfer (SCNT) has recently been achieved in human cells and sparked new interest in this technology. The authors reporting this methodical breakthrough speculated that SCNT would allow the creation of patient-matched embryonic stem cells, even in patients with hereditary mitochondrial diseases. However, herein we show that mismatched mitochondria in nuclear-transfer-derived embryonic stem cells (NT-ESCs) possess alloantigenicity and are subject to immune rejection. In a murine transplantation setup, we demonstrate that allogeneic mitochondria in NT-ESCs, which are nucleus-identical to the recipient, may trigger an adaptive alloimmune response that impairs the survival of NT-ESC grafts. The immune response is adaptive, directed against mitochondrial content, and amenable for tolerance induction. Mitochondrial alloantigenicity should therefore be considered when developing therapeutic SCNT-based strategies.

[1]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.

[2]  Daniel T. Montoro,et al.  Transplanted Terminally Differentiated Induced Pluripotent Stem Cells Are Accepted By Immune Mechanisms Similar To Self-Tolerance , 2014, Nature Communications.

[3]  W. Sanger,et al.  Producing primate embryonic stem cells by somatic cell nuclear transfer , 2007, Nature.

[4]  Luísa Pereira,et al.  mtDNA phylogeny and evolution of laboratory mouse strains. , 2007, Genome research.

[5]  M. West,et al.  Long-term bovine hematopoietic engraftment with clone-derived stem cells. , 2005, Cloning and stem cells.

[6]  Robert C. Edgar,et al.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity , 2004, BMC Bioinformatics.

[7]  G. Butcher,et al.  Generation of T cells with lytic specificity for atypical antigens. I. A mitochondrial antigen in the rat , 1991, The Journal of experimental medicine.

[8]  R. Jaenisch,et al.  Transnuclear Mice with Predefined T Cell Receptor Specificities Against Toxoplasma gondii Obtained via SCNT , 2010, Science.

[9]  Antigenic competition between minor (Non-H-2) histocompatibility antigens , 2004, Immunogenetics.

[10]  M. Levy,et al.  Human oocytes reprogram somatic cells to a pluripotent state. , 2012, World neurosurgery.

[11]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[12]  R. Robbins,et al.  Prevention and Inhibition But Not Reversion of Chronic Allograft Vasculopathy by FK778 , 2008, Transplantation.

[13]  Howard T. Jacobs,et al.  Premature ageing in mice expressing defective mitochondrial DNA polymerase , 2004, Nature.

[14]  J. Platt,et al.  Xeno—still stuck without αGal , 2003, Nature Biotechnology.

[15]  James J. Yoo,et al.  Generation of histocompatible tissues using nuclear transplantation , 2002, Nature Biotechnology.

[16]  R. Riblet,et al.  Maternally transmitted target antigen for unrestricted killing by NZB T lymphocytes , 1980, The Journal of experimental medicine.

[17]  H. Woo,et al.  Acute rejection after swine leukocyte antigen-matched kidney allo-transplantation in cloned miniature pigs with different mitochondrial DNA-encoded minor histocompatibility antigen. , 2013, Transplantation proceedings.

[18]  K. F. Lindahl,et al.  Identification of the rat maternally transmitted minor histocompatibility antigen. , 1997, Journal of immunology.

[19]  Dong Ryul Lee,et al.  Human somatic cell nuclear transfer using adult cells. , 2014, Cell stem cell.

[20]  C. Perreault,et al.  The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3. , 1996, Journal of immunology.

[21]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[22]  Shinya Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[23]  Olga Golosova,et al.  Unipro UGENE: a unified bioinformatics toolkit , 2012, Bioinform..

[24]  Yiping Gu,et al.  Role of MHC Class I in Immune Surveillance of Mitochondrial DNA Integrity1 , 2003, The Journal of Immunology.

[25]  A. Trounson,et al.  Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei , 2000, Current Biology.

[26]  K. F. Lindahl,et al.  MtDNA-encoded histocompatibility antigens. , 1995, Methods in enzymology.

[27]  Lisa E. Wagar,et al.  The Human Immune System Recognizes Neopeptides Derived from Mitochondrial DNA Deletions , 2014, The Journal of Immunology.

[28]  H. Yonekawa,et al.  Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein , 1990, Cell.

[29]  S. Mitalipov,et al.  Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer , 2013, Cell.

[30]  Perry G. Ridge,et al.  Mitochondrial genomic variation associated with higher mitochondrial copy number: the Cache County Study on Memory Health and Aging , 2014, BMC Bioinformatics.

[31]  N. Benvenisty,et al.  Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells , 2014, Nature.

[32]  P. Medawar,et al.  ‘Actively Acquired Tolerance’ of Foreign Cells , 1953, Nature.

[33]  H. Yonekawa,et al.  The innate immune system in host mice targets cells with allogenic mitochondrial DNA , 2010, The Journal of experimental medicine.